$WLK

Westlake (WLK) Q2 2026 Earnings Call Transcript

Westlake (WLK) reported Q2 2026 net sales of $3.3 billion, up from $3.0 billion a year earlier, and EBITDA of $679 million versus $340 million. The company cited $150 million of 3-pillar plan benefits and guided full-year HIP revenue of $4.4 to $4.6 billion and HIP EBITDA margin of 19% to 21%. Debt was reduced by $500 million.

Original reporting
Published Aug 11, 2026, 6:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 6:35 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Westlake (WLK) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$WLKNeutralMed
01

Why it matters

The transcript provides quantified operating performance and explicit full-year guidance ranges, including a lower-end expectation for HIP results and EBITDA margin due to residential construction softness, alongside positive catalysts like higher pricing, debt reduction, and facility acquisitions.

02

Market read

Traders can update models for Westlake’s 2026 HIP revenue and margin trajectory based on the lower-end guidance and the stated drivers (residential softness, cost and pricing improvements, and debt reduction).

03

What to watch

Debt retirement ($500M) and the Wilhelmshaven integration with North American feedstock could improve European margins more than the market expects, potentially offsetting residential weakness in HIP.

Relevance 8/10Novelty 7/10Timing: during/after the Aug. 4, 2026 earnings call

Background

Westlake’s Q2 2026 earnings call covers two segments, PEM (Performance and Essential Materials) and HIP (Housing and Infrastructure Products), with emphasis on pricing, volume, and a multi-pillar profitability plan.

Company-level read

Ticker impact

$WLKNeutralMedium confidence
Context

Westlake reported Q2 2026 net sales of $3.3B, EBITDA of $679M, and guided full-year HIP revenue to $4.4B-$4.6B at the lower end.

Expected impact

Near-term volatility likely as traders weigh lower-end guidance and residential softness against strong EBITDA improvement and pricing tailwinds.

Evidence & confidence

The transcript includes multiple quantified datapoints (sales, EBITDA, pricing, debt retirement, and full-year guidance ranges) that can drive repricing, but it is a call transcript rather than a fresh earnings release with explicit consensus comparison in the provided text.

Market effects

Chlor-alkali and PVC value-chain pricing sensitivity is highlighted via PEM average sales price up sequentially and caustic soda up sharply, reinforcing commodity-driven earnings volatility.

North American infrastructure and data center demand is cited as supporting HIP volumes, while residential construction is described as muted, implying divergent regional end-market momentum.

Middle East conflict is flagged as exacerbating volatility in export demand and selling prices for PEM products, a risk factor for global petrochemical spreads.

Counterpoint

The lower-end guidance may be more about timing and segment mix than fundamental demand deterioration, given management cites pull-forward into Q2 and strong pricing/volume drivers.

Key entities

  • Westlake Corporation

    Reported Q2 2026 results and provided full-year HIP revenue and EBITDA margin guidance, plus updates on debt retirement and facility integration.

  • Jean-Marc Gilson

    CEO who discussed pricing volatility drivers, chlorovinyls strategy, and profitability recovery in Epoxy.

  • Jon Baksht

    CFO who discussed revised HIP segment guidance, residential construction outlook, and potential timing effects on pipe sales volumes.

Related articles

$WLKMed

Westlake Q2 Earnings Call Highlights

Westlake Corp. (NYSE: WLK) discussed Q2 results and outlook on an earnings call. PEM volumes rose 2% QoQ, while polyethylene and PVC pricing trends were described. The company said its profitability plan added about $150M to Q2 and $300M to H1 EBITDA, targeting $600M in 2026. HIP sales were $1.3B (+8% YoY) with EBITDA $276M. 2026 guidance and capital allocation were also updated.

$WLKMed

WESTLAKE CORP (WLK): Results of Operations and Financial Condition

WESTLAKE CORP (WLK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991_20260630earningsrele.htm EX-99.1 Document EXHIBIT 99.1 WESTLAKE CORPORATION Contact—(713) 960-9111 Investors—Jonathan Baksht Media—L. Benjamin Ederington Westlake Corporation Reports Second Quarter 2026 Results • Significant improvement in net income and EBITDA fr

$WLKMedAI 8/10

Westlake Corporation Reports Second Quarter 2026 Results

Westlake Corporation (NYSE: WLK) reported Q2 2026 net sales of $3.3B, net income of $260M ($2.01/share), and EBITDA of $679M. The company said results improved versus Q1 2026 and Q2 2025, supported by PEM pricing and HIP volume. Westlake reduced debt by $500M, returned $99M to shareholders, and outlined a $600M operating income benefit plan.

$WLKMed

Chlorovinyl Manufacturing Expansion Asserts Westlake Corp (WLK) as a Top Mid-Cap Stock to Own for Decades, According to Hedge Funds

Westlake Corp (NYSE:WLK) completed, via its German unit Westlake Vinnolit GmbH & Co. KG, the acquisition of a chlorovinyl production site in Wilhelmshaven, Germany. The facility could produce 380,000 metric tons of PVC annually, expanding Westlake’s European and North American footprint. Mizuho reiterated Neutral but cut its price target to $88 from $110.

$WLKMed

Westlake Corporation: Westlake Expands Global Chlorovinyls Manufacturing Capacity With Acquisition of PVC and VCM Plants in Wilhelmshaven, Germany

Westlake Corporation (NYSE: WLK) said its German subsidiary, Westlake Vinnolit GmbH Co. KG, completed the acquisition of a PVC and vinyl chloride monomer production site in Wilhelmshaven, Germany. The plant, previously under insolvency administration, has capacity to produce 380,000 metric tons of PVC annually. Westlake said the deal expands its chlorovinyls footprint in Europe and North America.

$ARESHighAI 8/10

Ares Management Stock: Analyst Estimates & Ratings

Ares Management (ARES) underperformed the S&P 500 and XLF ETF over the past year, with a 20.8% decline. Q2 revenue missed estimates at $1.26B, while EPS met expectations at $1.29. Analysts have a 'Moderate Buy' consensus, with a mean price target of $150.80, suggesting a 6.8% upside.